Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

A highly efficient platform for detection of SARS-CoV-2 variants

A highly efficient platform for detection of SARS-CoV-2 variants

Vaccine component BNT162b4 enhances T-cell immunity against SARS-CoV-2 variants for reduced COVID-19 disease severity

Vaccine component BNT162b4 enhances T-cell immunity against SARS-CoV-2 variants for reduced COVID-19 disease severity

Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19

Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19

Is there an association between COVID-19 and the risk of developing an autoimmune disease?

Is there an association between COVID-19 and the risk of developing an autoimmune disease?

Pregnant women show unique immune response to COVID-19

Pregnant women show unique immune response to COVID-19

How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity

How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity

Study finds positive association between obesity and COVID-19 mortality across 142 countries

Study finds positive association between obesity and COVID-19 mortality across 142 countries

Study uncovers a novel fold within the SARS-CoV-2 replication co-factor non-structural protein 9

Study uncovers a novel fold within the SARS-CoV-2 replication co-factor non-structural protein 9

Antibody response to SARS-CoV-2 is stronger and more durable in infants and young children

Antibody response to SARS-CoV-2 is stronger and more durable in infants and young children

Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults

Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults

The neural mechanisms causing long-COVID fatigue

The neural mechanisms causing long-COVID fatigue

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Study suggests detecting new SARS-CoV-2 variants in inbound travelers more effective than community surveillance

Study suggests detecting new SARS-CoV-2 variants in inbound travelers more effective than community surveillance

Study finds no association between maternal SARS-CoV-2 infection and infant neurodevelopment

Study finds no association between maternal SARS-CoV-2 infection and infant neurodevelopment

US adults with post-COVID-19 condition more likely to face healthcare access and affordability challenges

US adults with post-COVID-19 condition more likely to face healthcare access and affordability challenges

Nirmatrelvir-ritonavir reduces risk of post-COVID syndrome in non-hospitalized vaccinated patients

Nirmatrelvir-ritonavir reduces risk of post-COVID syndrome in non-hospitalized vaccinated patients

The virological characteristics of XBB.1.16

The virological characteristics of XBB.1.16

Pediatric invasive group A Streptococcal infections on the rise during respiratory virus outbreak

Pediatric invasive group A Streptococcal infections on the rise during respiratory virus outbreak

The identification of vaccinee-derived antibodies with broad-spectrum Omicron neutralization activity

The identification of vaccinee-derived antibodies with broad-spectrum Omicron neutralization activity

An extremely rare case report of rebound multi-system inflammatory syndrome in children

An extremely rare case report of rebound multi-system inflammatory syndrome in children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.